This discovery not only elucidates the critical regulatory role of the ACE‐PSAP‐GPR37 axis in IDD but also provides an important theoretical foundation for developing therapeutic strategies targeting PSAP metabolic pathways. Here, GPR37 is linked to intervertebral disk degenerative disorder.